INDO US BIOTECH LTD (INDOUS)

NSE: ₹98.35
BSE: ₹98.00
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Mar 2021 Sep 2021 Mar 2022
Revenue from Operations 2,324,149.68 25.51 24.55
YOY Revenue Growth % - - -
Other Income 4,079.53 0.02 0.16
Total Income 2,328,229.21 25.53 24.71
Total Expenses + 2,090,166.93 22.94 21.99
Cost of Materials Consumed 1,223,974.59 1.02 1.15
Employee Benefit Expense 19,704.49 0.30 0.41
Other Expenses 744,132.32 2.66 3.76
Operating Profit 233,982.74 2.57 2.56
OPM % 10.1% 10.1% 10.4%
Profit Before Tax + 238,062.27 2.59 2.72
Tax Expense -103,713.08 2.59 2.72
Tax % -43.6% 100% 100%
Profit After Tax 341,775.35 0.00 0.00
EPS (Basic) 5.63 4.06 4.21

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2022 Mar 2021
Revenue from Operations 50.06 4,011,032.71
YOY Revenue Growth % -100% -
Other Income 0.18 4,298.76
Total Income 50.24 4,015,331.47
Total Expenses + 44.93 3,622,429.10
Cost of Materials Consumed 2.18 2,511,223.03
Employee Benefit Expense 0.71 51,513.17
Other Expenses 6.42 901,904.77
Operating Profit 5.13 388,603.60
OPM % 10.2% 9.7%
Profit Before Exceptional 0.00 392,902.36
Exceptional Items 0.00 0.00
Profit Before Tax + 5.31 392,902.36
Tax Expense 5.31 -97,069.08
Tax % 100% -24.7%
Profit After Tax 0.00 489,971.44
EPS (Basic) 8.27 8.08

Balance Sheet

Particulars Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 8.78 557,258.21
Property, Plant & Equipment 0.00 237,035.39
Capital Work in Progress 0.00 198,576.90
Non-Current Investments 0.00 0.00
Goodwill 0.00 0.00
Other Intangible Assets 0.00 0.00
Current Assets + 46.84 3,813,476.34
Inventories 23.36 1,187,965.45
Trade Receivables 0.00 2,470,599.07
Cash and Cash Equivalents 0.05 13,442.24
Current Investments 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 2,134,248.28
Equity Share Capital 0.00 606,799.00
Other Equity 0.00 1,527,402.86
Non-Current Liabilities 4.82 422,044.68
Current Liabilities 12.28 1,814,441.59
Total Liabilities 0.00 2,236,486.27

Cash Flow Statement

Particulars Mar 2022 Mar 2021
Cash from Operating Activities 2.70 43,647.95
Cash from Investing Activities 5.45 212,765.70
Cash from Financing Activities 5.31 388,660.87
Net Increase/Decrease in Cash 13.46 645,074.52